SONAM KHANJAE: Open Payments
NPI 1063066017 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 21 payments from 5 companies in 2025. Trend: 2023 $189 · 2024 $309 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $366 |
| Optinose US, Inc. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $15 |
Products named: DUPIXENT, Xhance, KEYTRUDA, Ryaltris.
Industry payments across TX — which companies pay providers there.
